Category Regulatory and policy issues

FDA Q & A about the end of the compliance and enforcement policy for certain human cells, tissues or cellular or tissue-based products

The US FDA has published a detailed Q & A about the end of the compliance and enforcement policy for certain human cells, tissues or cellular or tissue based products (HCT/Ps). As stated in the guidance, Regulatory Considerations for Human Cells,…

Read MoreFDA Q & A about the end of the compliance and enforcement policy for certain human cells, tissues or cellular or tissue-based products